Capital Performance Advisors »

Werewolf Therapeutics shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Werewolf Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Werewolf Therapeutics held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Werewolf Therapeutics by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $127 60 2.12

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)

View all positions for Capital Performance Advisors

Top funds holding Werewolf Therapeutics

RA Capital Management
MPM Asset Management
Partner Fund Management
MPM Oncology Impact Management
Bank of America Corporation
BlackRock
BlackRock
Rubric Capital Management
Vanguard Group
Eagle Health Investments
Geode Capital Management
Sphera Funds Management
DC Funds
State Street Corporation
Acadian Asset Management

View all funds holding Werewolf Therapeutics